Target detail
ACE2
angiotensin converting enzyme 2
Data: Live structured evidence (Supabase)
Foundation row from public.targets — full Open Targets / ChEMBL preload remains a future operator job (Phase 8H+).
Display name: angiotensin converting enzyme 2
Aliases: ACE2, angiotensin converting enzyme 2
Type / organism: protein_coding · Homo sapiens
Source: opentargets · ENSG00000130234
Index freshness: last_synced_at 2026-05-15T18:59:06.842+00:00 · updated 2026-05-15T18:59:07.260572+00:00
Limitations & build flags
- Read-only structured navigator
- No clinical outcome benefit inferred
- Trial presence does not imply success
- Drug identity may require normalization
- Terminated/withdrawn trials must remain visible
This symbol is listed in public.targets (operator seed or future preload). Connector-backed sections below may still show empty states until ChEMBL / Open Targets / ClinicalTrials.gov mirror rows exist for this marker.
Connectors represented in loaded rows for ACE2. Empty groups mean no matching rows — not a claim about biology or clinical use.
- Open TargetsLive when indexed
Disease–target evidence rows when operators run enrich:opentargets (GraphQL from trusted scripts only).
- ChEMBLLive when indexed
Drug–target and related enrichment rows when operators run enrich:chembl (server/CLI only).
- CANTI signal builderLive when indexed
Deterministic repurposing-signal rows produced by the in-repo signal builder when operators run the build pipeline.
Rows from disease_target_evidence for this symbol.
glioblastoma
literature · opentargets
Drug records tied via drug_targets — mechanistic linkage only.
CHEMBL4202767
chembl4202767
CHEMBL260273
chembl260273
CHEMBL5594653
chembl5594653
CHEMBL409105
chembl409105
CHEMBL258464
chembl258464
MYRICETIN
chembl164
CHEMBL5422206
chembl5422206
CHEMBL163454
chembl163454
CHEMBL269997
chembl269997
CHEMBL5437403
chembl5437403
CHEMBL398940
chembl398940
CHEMBL5415414
chembl5415414
CHEMBL5078837
chembl5078837
CHEMBL5267016
chembl5267016
CHEMBL4546207
chembl4546207
CHEMBL408182
chembl408182
CHEMBL4455145
chembl4455145
CHEMBL251808
chembl251808
CHEMBL384120
chembl384120
CHEMBL5403774
chembl5403774
BI-1942
chembl3640116
CHEMBL5426568
chembl5426568
CHEMBL5400083
chembl5400083
CHEMBL261423
chembl261423
CHEMBL5397691
chembl5397691
CHEMBL5396932
chembl5396932
CHEMBL5400018
chembl5400018
CHEMBL263663
chembl263663
CHEMBL5270769
chembl5270769
CHEMBL4517893
chembl4517893
CHEMBL258333
chembl258333
CHEMBL4454286
chembl4454286
CHEMBL5274408
chembl5274408
BI 1230
chembl4588900
CHEMBL257726
chembl257726
CHEMBL254900
chembl254900
CHEMBL4878106
chembl4878106
CHEMBL5171650
chembl5171650
CHEMBL5429562
chembl5429562
CHEMBL4460127
chembl4460127
CHEMBL4450911
chembl4450911
CEPHARANTHINE
chembl449782
CHEMBL257727
chembl257727
CHEMBL4469059
chembl4469059
CHEMBL261033
chembl261033
CHEMBL414173
chembl414173
HONOKIOL
chembl16901
CHEMBL400526
chembl400526
CHEMBL5397255
chembl5397255
CHEMBL473326
chembl473326
HEMATEIN
chembl1360563
CHEMBL271225
chembl271225
CHEMBL4471138
chembl4471138
CHEMBL4472399
chembl4472399
CHEMBL5220968
chembl5220968
XERUBORBACTAM
chembl4633785
CINACALCET
chembl1201284
CHEMBL5275219
chembl5275219
CHLOROQUINE
chembl76
EMODIN
chembl289277
CHEMBL5420290
chembl5420290
CHEMBL5205832
chembl5205832
CHEMBL5395954
chembl5395954
CHEMBL5394053
chembl5394053
CHEMBL1240682
chembl1240682
CHEMBL5081573
chembl5081573
CHEMBL408705
chembl408705
CHEMBL402987
chembl402987
CANNABIDIOL
chembl190461
CHEMBL5429801
chembl5429801
CHEMBL5187952
chembl5187952
CHEMBL5430631
chembl5430631
CHEMBL436639
chembl436639
CHEMBL404117
chembl404117
CHEMBL4543432
chembl4543432
CHEMBL4071326
chembl4071326
HYDROXYCHLOROQUINE
chembl1535
CHEMBL4081997
chembl4081997
CHEMBL405913
chembl405913
CHEMBL252391
chembl252391
CHEMBL5282197
chembl5282197
CHEMBL5402703
chembl5402703
CHEMBL253428
chembl253428
CHEMBL5431714
chembl5431714
CHEMBL410509
chembl410509
CHEMBL271223
chembl271223
CHEMBL260677
chembl260677
CHEMBL3235416
chembl3235416
CHEMBL254911
chembl254911
CHEMBL271224
chembl271224
CHEMBL5173280
chembl5173280
CHEMBL5277567
chembl5277567
CHEMBL4080520
chembl4080520
CHEMBL4439726
chembl4439726
CHEMBL5410380
chembl5410380
CHEMBL5633998
chembl5633998
CHEMBL254703
chembl254703
CHEMBL257270
chembl257270
CHEMBL5423943
chembl5423943
CHEMBL3219078
chembl3219078
CHEMBL398545
chembl398545
CHEMBL4458011
chembl4458011
CHEMBL254493
chembl254493
CHEMBL4848278
chembl4848278
CHEMBL5591272
chembl5591272
CHEMBL5575279
chembl5575279
CHEMBL4860365
chembl4860365
CHEMBL5434641
chembl5434641
CHEMBL5220314
chembl5220314
CHEMBL5283695
chembl5283695
CHEMBL257026
chembl257026
CHEMBL4438924
chembl4438924
CHEMBL4871893
chembl4871893
CHEMBL4464521
chembl4464521
CHEMBL5429094
chembl5429094
CHEMBL3414622
chembl3414622
CHEMBL412123
chembl412123
CHEMBL5281591
chembl5281591
CHEMBL4847430
chembl4847430
CHEMBL5433304
chembl5433304
CHEMBL258683
chembl258683
CHEMBL5270175
chembl5270175
CHEMBL409713
chembl409713
CHEMBL5407252
chembl5407252
ANALOG OF DYNORPHIN A
chembl405618
CHEMBL5563850
chembl5563850
CHEMBL4545947
chembl4545947
CHEMBL5570585
chembl5570585
CHEMBL264665
chembl264665
BI 665915
chembl3417525
CHEMBL5421393
chembl5421393
CHEMBL5277148
chembl5277148
CHEMBL5433480
chembl5433480
CHEMBL4878091
chembl4878091
CHEMBL5284169
chembl5284169
CHEMBL5631690
chembl5631690
CHEMBL350414
chembl350414
CHEMBL4464588
chembl4464588
ORE-1001
chembl429844
CHEMBL411298
chembl411298
CHEMBL401086
chembl401086
CHEMBL500351
chembl500351
CHEMBL251804
chembl251804
CHEMBL4859711
chembl4859711
CHEMBL404044
chembl404044
CHEMBL254495
chembl254495
CHEMBL5410572
chembl5410572
CHEMBL437595
chembl437595
CHEMBL5631254
chembl5631254
CHEMBL4451026
chembl4451026
FLUORESCEIN
chembl1057
CHEMBL398771
chembl398771
CHEMBL5399209
chembl5399209
CHEMBL4444926
chembl4444926
CHEMBL4785828
chembl4785828
CHEMBL261121
chembl261121
CHEMBL4445648
chembl4445648
CHEMBL5575999
chembl5575999
CHEMBL5088125
chembl5088125
CHEMBL4560468
chembl4560468
CHEMBL5092803
chembl5092803
CHEMBL5279656
chembl5279656
CHEMBL5424641
chembl5424641
CHEMBL4868121
chembl4868121
CHEMBL4468952
chembl4468952
CHEMBL252417
chembl252417
CHEMBL272925
chembl272925
CHEMBL5087608
chembl5087608
CHEMBL5270233
chembl5270233
DIMINAZENE
chembl35241
CHEMBL4450628
chembl4450628
CHEMBL252003
chembl252003
CHEMBL253224
chembl253224
CHEMBL5632620
chembl5632620
CHEMBL5574160
chembl5574160
CHEMBL4545274
chembl4545274
CHEMBL5426290
chembl5426290
CHEMBL5281306
chembl5281306
CHEMBL5401243
chembl5401243
CHEMBL401397
chembl401397
CHEMBL5081268
chembl5081268
CHEMBL5420202
chembl5420202
CHEMBL5406655
chembl5406655
CHEMBL5427649
chembl5427649
CHEMBL5415513
chembl5415513
CHEMBL5276399
chembl5276399
CHEMBL254282
chembl254282
CHEMBL269996
chembl269996
CHEMBL5572893
chembl5572893
ARIPIPRAZOLE
chembl1112
CHEMBL5273921
chembl5273921
CHEMBL409721
chembl409721
CHEMBL5434946
chembl5434946
CHEMBL5631509
chembl5631509
CHEMBL405232
chembl405232
CHEMBL411942
chembl411942
CHEMBL5436660
chembl5436660
CHEMBL251809
chembl251809
CHEMBL5091821
chembl5091821
CHEMBL408448
chembl408448
disease_drug_evidence rows on linked drugs whose evidence_type suggests approved-elsewhere discussion context.
No matching rows
Import repoDB-compatible disease–drug evidence or add structured rows to surface discussion candidates here.
Mirror rows whose text fields mention this symbol — registry context only.
No matching live evidence found
Populate clinical_trials via the registry enrichment flow; this panel matches the symbol token in titles, conditions, or interventions.
Repurposing signal rows for drugs linked to this target via drug_targets.
Repurposing research signal · ARIPIPRAZOLE · v0.1
Deterministic research signal for ARIPIPRAZOLE. Aggregate template score 55 (not a clinical endpoint). Contributing canonical sources observed in this rollup: chembl, opentargets. No failed-repoDB or terminated-trial penalty lines fired for this rollup. Missing relative to the Phase 8A template: glioma/brain-tumor–scoped ClinicalTrials.gov disease–drug evidence; repoDB-style disease–drug labels. This row requires clinical/research review before any operational use — not care-planning guidance, dose planning, or outcome-benefit claims.
Open signals hubStructured rows with negative evidence_direction on disease–drug or signal tables.
No negative-direction rows
When structured evidence includes explicit negative direction fields, they surface here for oncology review.
No ClinicalTrials.gov mirror rows mention this symbol in titles, conditions, or interventions (within the loaded window).
- chembl: 217
- opentargets: 1
- canti_signal_builder: 1
Structured evidence rows link this marker to cohort contexts when ingested — interpret as research context only.
Disease contexts
0
Linked drugs
0
Linked in dataset
0
Research signals
0
Doctor-discussion candidate and related tags are descriptive only.
Signals list: Live structured evidence (Supabase)
Repurposing research signal · ARIPIPRAZOLE · v0.1
Deterministic research signal for ARIPIPRAZOLE. Aggregate template score 55 (not a clinical endpoint). Contributing canonical sources observed in this rollup: chembl, opentargets. No failed-repoDB or terminated-trial penalty lines fired for this rollup. Missing relative to the Phase 8A template: glioma/brain-tumor–scoped ClinicalTrials.gov disease–drug evidence; repoDB-style disease–drug labels. This row requires clinical/research review before any operational use — not care-planning guidance, dose planning, or outcome-benefit claims.
View signals hub